Ifp Advisors, Inc Ardelyx, Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$3.23 - $4.95 $80 - $123	25 New	25 $0
Q4 2022 Feb 07, 2023	BUY	$1.22 - $2.85 $12,200 - $28,500	10,000 New	10,000 $40,000
Q3 2021 Oct 06, 2021	SELL	$1.27 - $8.17 $1,905 - $12,255	-1,500 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$6.55 - $8.98 $9,825 - $13,470	1,500 New	1,500 $11,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.